CONTINENTAL STRATEGY, LLC

Lobbying for NRX PHARMACEUTICALS · Clinical biopharma company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · $75,000.00 income · posted Jan 19, 2026

Lobbying activity 1

Pharmacy

Issues regarding lifesaving treatments

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem